BioSpace News Archive

AmerStem, a biotechnology company dedicated to mastering the potential of plants and plant cultures for the production of high-value phytochemicals, announces that it has developed a platform technology that allows the establishment and maintenance of large-scale, sustainable plant cultures

Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX), a company specializing in developing pharmaceutical product candidates for pain management, today announced the results of a sciatic nerve preclinical study in rabbits designed to evaluate nerve damage from locally injected Probudur, Virpaxs liposomal bupivacaine product candidate.

CYduct Diagnostics, Inc. (OTC PINK:CYDX) announced that it has entered into a Sponsored Research Agreement, effective April 1, 2021, with Yale University to test and evaluate the performance of the Universitys nanowire biosensor technology for detecting critical protein biomarkers associated with the progression of Breast Cancer.

Rare Disease Therapeutics, Inc. Announces New Expanded FDA Approved Indication for Antivenom ANAVIP ® for Treatment of North American Pit Viper Envenomation ANAVIP Now Indicated for Management of Adult and Pediatric Patients with All North American Pit Viper Envenomation, Including Rattlesnake, Copperhead, and Cottonmouth/Water Moccasin Bites

BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Ken Londoner, CEO of BioSig Technologies, will provide a corporate overview and business update at the 20 th Annual Needham Virtual Healthcare Conference on Monday, April 12

The experience of living with dementia, or caring for someone living with dementia, can differ across Canada, depending on culture, language, racial or equity barriers, and most of all, stigma

Economic activity in the services sector grew in March for the 10th month in a row, say the nation’s purchasing and supply executives in the latest Services ISM® Report On Business®.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced new preclinical research demonstrating the ability of VIR-7831, the company’s investigational SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2) monoclonal antibody (mAb), to maintain its neutralizing activity against a mutation in the receptor binding domain (RBD) of SARS-CoV-2, called L452R,

IceCure Medical Ltd. (TASE: ICCM) (“IceCure” or the “Company”), developer of the next generation cryoablation technology that destroys tumors by freezing, announced today that it has been granted Designation as a Breakthrough Device from the U.S. Food and Drug Administration (FDA) for its lead asset, ProSense®, and proposed indication for use

Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, is proud to be Certified™ by Great Place to Work®.